Unlike the array of new injectable GLP-1 drugs, there is only one oral GLP-1 medicine that is currently on the market: Novo Nordisks Rybelsus
Global, regional, and national temporal trends in incidence for type 2 diabetes mellitus related chronic kidney disease from 1992 to 2021
While there can be a number of mostly gastro-intestinal side-effects from Tirzepatide and others (acid reflux, burping, constipation, nausea) by starting at a really low dose, increasing slowly and not going too high on the dose most of these types of side-effects can be minimized
This metabolic reality means the deficit that produced initial weight loss gradually shrinks as you get smaller, even without changing your intake
In 2014, an influential study by Wang et al